Literature DB >> 7980449

Regulation of basal adenylate cyclase activity in neuroblastoma x glioma hybrid, NG108-15, cells transfected to express the human beta 2 adrenoceptor: evidence for empty receptor stimulation of the adenylate cyclase cascade.

E J Adie1, G Milligan.   

Abstract

Clones of neuroblastoma x glioma hybrid, NH108-15, cells expressing differing levels of the human beta 2 adrenoceptor were isolated. Two clones were examined in detail, beta N22 which expressed some 4000 fmol/mg of membrane protein and clone beta N17 which expressed approx. 300 fmol/mg of membrane protein of the receptor. In beta N22 cells 'basal' adenylate cyclase activity measured in the presence of Mg2+ was significantly greater than that in wild-type NG108-15 or beta N17 cells. Both isoprenaline and iloprost were able to stimulate adenylate cyclase activity in each of beta N22 and beta N17 membranes. However, the EC50 for isoprenaline stimulation of adenylate cyclase in membranes of beta N22 cells (6 nM) was significantly lower than that in membranes of beta N17 cells (80 nM), whereas the EC50 for iloprost stimulation of adenylate cyclase (approx. 25 nM) was the same in the two clones and in parental NG108-15 cells. The high basal adenylate cyclase activity of beta N22 cell membranes was not a reflection of higher levels of expression of the adenylate cyclase catalytic unit, as adenylate cyclase activity measured in the presence of Mn2+ was equivalent in membranes of each of wild-type NG108-15 cells and clones beta N22 and beta N17. Basal adenylate cyclase activity measured in the presence of Mg2+ in clone beta N22 was significantly reduced, however, by the beta-receptor antagonist propranolol, whereas this agent was without effect on basal adenylate cyclase activity in membranes of wild-type NG108-15 cells. These data indicate that the elevated basal adenylate cyclase cascade in NG108-15 cells expressing high levels of the beta 2 adrenoceptor represents empty receptor activation of the signalling cascade.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980449      PMCID: PMC1137618          DOI: 10.1042/bj3030803

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Assay of adenylyl cyclase catalytic activity.

Authors:  R A Johnson; Y Salomon
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  GTPase-deficient G alpha i2 oncogene gip2 inhibits adenylylcyclase and attenuates receptor-stimulated phospholipase A2 activity.

Authors:  J M Lowndes; S K Gupta; S Osawa; G L Johnson
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty.

Authors:  A Shenker; L Laue; S Kosugi; J J Merendino; T Minegishi; G B Cutler
Journal:  Nature       Date:  1993-10-14       Impact factor: 49.962

5.  Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.

Authors:  T Costa; A Herz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Quantitative stoichiometry of the proteins of the stimulatory arm of the adenylyl cyclase cascade in neuroblastoma x glioma hybrid, NG108-15 cells.

Authors:  G D Kim; E J Adie; G Milligan
Journal:  Eur J Biochem       Date:  1994-01-15

7.  Persistent activation of the alpha subunit of Gs promotes its removal from the plasma membrane.

Authors:  G Milligan; C G Unson
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

8.  Prostaglandin E1-mediated, cyclic AMP-independent, down-regulation of Gs alpha in neuroblastoma x glioma hybrid cells.

Authors:  F R McKenzie; G Milligan
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

9.  Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions.

Authors:  T Costa; J Lang; C Gless; A Herz
Journal:  Mol Pharmacol       Date:  1990-03       Impact factor: 4.436

10.  Agonist regulation of cellular Gs alpha-subunit levels in neuroblastoma x glioma hybrid NG108-15 cells transfected to express different levels of the human beta 2 adrenoceptor.

Authors:  E J Adie; G Milligan
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

View more
  12 in total

1.  Non-competitive antagonism of beta(2)-agonist-mediated cyclic AMP accumulation by ICI 118551 in BC3H1 cells endogenously expressing constitutively active beta(2)-adrenoceptors.

Authors:  H E Hopkinson; M L Latif; S J Hill
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors.

Authors:  M J Smit; R Leurs; A E Alewijnse; J Blauw; G P Van Nieuw Amerongen; Y Van De Vrede; E Roovers; H Timmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Detection and analysis of agonist-induced formation of the complex of the stimulatory guanine nucleotide-binding protein with adenylate cyclase in intact wild-type and beta 2-adrenoceptor-expressing NG108-15 cells.

Authors:  G D Kim; I C Carr; G Milligan
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

4.  Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the beta 2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity.

Authors:  D J MacEwan; G D Kim; G Milligan
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

Review 5.  Review: amino acid domains involved in constitutive activation of G-protein-coupled receptors.

Authors:  P J Pauwels; T Wurch
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

6.  A constitutively active mutant of the alpha 1B-adrenergic receptor can cause greater agonist-dependent down-regulation of the G-proteins G9 alpha and G11 alpha than the wild-type receptor.

Authors:  T W Lee; A Wise; S Cotecchia; G Milligan
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

7.  Antipsychotics with inverse agonist activity at the dopamine D3 receptor.

Authors:  N Griffon; C Pilon; F Sautel; J C Schwartz; P Sokoloff
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Analysis of inverse agonism at the delta opioid receptor after expression in Rat 1 fibroblasts.

Authors:  I Mullaney; I C Carr; G Milligan
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

9.  Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus.

Authors:  D E Selley; C C Cao; Q Liu; S R Childers
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

10.  Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.

Authors:  Jean-Christophe Corvol; Marie-Paule Muriel; Emmanuel Valjent; Jean Féger; Naïma Hanoun; Jean-Antoine Girault; Etienne C Hirsch; Denis Hervé
Journal:  J Neurosci       Date:  2004-08-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.